What's new?
-
Now open! Biotech grants worth up to $100,000We know how hard it is to take your science from lab to market. So we’re offering young biotech companies in North America and Europe the chance to win up to $100,000 in products and instruments per region. -
Cell-free DNA from liquid biopsiesFrom biomarker research to personalized medicine, cell-free DNA isolated from liquid biopsies provides a powerful method to monitor cancer development in future. Enjoy three talks by cancer researchers and “Ask-Me-Anything” sessions with R&D experts.
-
Thank you for voting!This year, we highlighted stars of cancer research and made a donation for each of your votes in our live polls. QIAGEN doubled that and donated a total of 1100 US$ to support the DKMS in fighting blood cancer. You can see the polls on genomics, liquid biopsy, RNA biomarkers and microbiome. Thank you for participating! -
Multianalyte Liquid BiopsiesWorking with cell-free DNA, extracellular vesicles or CTCs? How would the picture change if all analytes could be investigated from the same sample?
Stars of cancer research
Get up close and personal with star cancer researchers from around the world. Read about their experiences, thoughts and visions.-
Elaine Mardis, Columbus, Ohio, USA“I’m constantly inspired by cancer patients, especially our pediatric patients, and their families.” -
Klaus Pantel, Hamburg, Germany“Each year almost 10 million people die of cancer worldwide and to contribute translational cancer research with the potential to reduce this number is my strongest motivation.” -
Pithi Chanvorachote, Bangkok, Thailand“Understanding the defined molecular network and signaling of cancers can lead to discovering the ultimate drug targets that can then result in the best treatment.” -
Sabine Kasimir-Bauer, Essen, Germany“I have built a wonderful scientific network and made friends with people from all over the world.”
-
Seock-Ah Im, Seoul, Republic of Korea“We must build a more comprehensive network to facilitate academia, global pharmaceutical company and the biotechnology industry to run together.” -
Sue Branford, Adelaide, Australia“We continue to work toward finding the reasons why some patients don’t have a successful outcome.” -
Toh Han Chong, Singapore“Learn from setbacks, come back stronger, love the journey of discovery and creating new knowledge, and always have a dream, vision and hope.” -
You?What inspires you to do cancer research? We are happy to give these insights into the lives and work of cancer researchers. If you would like to share your story here, get in touch.
QIAGEN Cancer Research Online Events
Consortia and initiatives – we're working together
QIAGEN participates in numerous renowned international consortia, grant projects and initiatives that strive to improve global healthcare. They extend and access networks and infrastructures – and stimulate exchange between all relevant stakeholders – from science, medicine and government. Our active role in consortia and initiatives keeps QIAGEN at the forefront of scientific findings and developments.
- European Liquid Biopsy Society (ELBS)
- Cancer ID – a new way to track cancer
- SPIDIA4P – better diagnosis and medical research
- CBmed – biomarker identification, validation and research
- EASI-Genomics – cutting-edge DNA sequencing technologies
- EU-STANDS4PM – standards for in silico approaches in personalized medicine